CD4+CD8+(thymocyte-like) T lymphocytes present in blood and skin from patients with atopic dermatitis suggest immune dysregulation

被引:43
作者
Bang, K [1 ]
Lund, M
Wu, K
Mogensen, SC
Thestrup-Pedersen, K
机构
[1] Marselisborg Hosp, Dept Dermatol, DK-8000 Aarhus C, Denmark
[2] Aarhus Univ, Dept Med Microbiol & Immunol, DK-8000 Aarhus, Denmark
关键词
co-expression; interleukin-2; interleukin-4; T-lymphocyte phenotype;
D O I
10.1046/j.1365-2133.2001.04223.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Atopic dermatitis (AD) is a chronic inflammatory skin disease expressed early in life. Disease development is primarily determined by as yet unknown genetic factors, leading to the accumulation of activated T lymphocytes in the skin. Objectives To investigate the nature of these T cells. Methods T-cell lines could be established from AD skin biopsies, but not from normal skin or AD peripheral blood, when placed in RPMI 1640 medium with 10% human AB serum, antibiotics, and the T-lymphocyte growth factors interleukins 2 and 4. The cell lines were subjected to phenotypic analysis using a fluorescence-activated cell sorter and compared with lymphocytes from AD and normal control peripheral blood. Results T-cell lines from 22 of 24 consecutive skin biopsies taken from 24 adult patients with AD were established. All cells were T lymphocytes expressing several activation markers. A significant proportion of the lymphocytes had stable expression of a CD4+ CD8+ phenotype (26% +/- 6%; mean +/- SEM). Such double-positive T lymphocytes are normally only seen in the thymus and not in the peripheral immune system. CD4+ CD8+ cells in peripheral blood of the patients (12.5% +/- 3.3%) were also detected. Conclusions We suggest that a basic pathophysiological change in AD may be a faulty maturation of the T-lymphocyte system, leading to skin inflammation with CD4+ CD8+ T lymphocytes resembling immature T cells. This is likely to lead to skewing of many immune reactions in the patients.
引用
收藏
页码:1140 / 1147
页数:8
相关论文
共 29 条
  • [1] [Anonymous], ACTA DERM VENERE S92, DOI [10.2340/00015555924447, DOI 10.2340/00015555924447]
  • [2] Aversa G, 1997, J IMMUNOL, V158, P4036
  • [3] BANG K, 2001, IN PRESS ACTA DERM V
  • [4] BERRIH S, 1981, CLIN EXP IMMUNOL, V45, P1
  • [5] BLUE ML, 1987, J IMMUNOL, V139, P1065
  • [6] A NOVEL RECEPTOR INVOLVED IN T-CELL ACTIVATION
    COCKS, BG
    CHANG, CCJ
    CARBALLIDO, JM
    YSSEL, H
    DEVRIES, JE
    AVERSA, G
    [J]. NATURE, 1995, 376 (6537) : 260 - 263
  • [7] T-CELL CULTURES AND THE HAYFLICK LIMIT
    EFFROS, RB
    WALFORD, RL
    [J]. HUMAN IMMUNOLOGY, 1984, 9 (01) : 49 - 65
  • [8] Activation of CD8+ T lymphocytes through the T cell receptor turns on CD4 gene expression:: Implications for HIV pathogenesis
    Flamand, L
    Crowley, RW
    Lusso, P
    Colombini-Hatch, S
    Margolis, DM
    Gallo, RC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (06) : 3111 - 3116
  • [9] Hank JA, 1999, CLIN CANCER RES, V5, P281
  • [10] LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS
    HAYFLICK, L
    [J]. EXPERIMENTAL CELL RESEARCH, 1965, 37 (03) : 614 - &